Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.

Human pathology - 1 Dec 2011

Minner Sarah, Kraetzig Franziska, Tachezy Michael, Kilic Ergin, Graefen Markus, Wilczak Waldemar, Bokemeyer Carsten, Huland Hartwig, Sauter Guido, Schlomm Thorsten

Abstract excerpt

Activated leukocyte cell adhesion molecule (CD166) is a member of the immunoglobulin superfamily and is aberrantly expressed in different tumors, including prostate cancer. To learn more on the prevalence and clinical significance of activated leukocyte cell adhesion molecule expression in prostate cancer, a tissue microarray containing 3261 primary prostate cancers treated by radical prostatectomy was used. A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Adhesion Molecules, Neuronal
Share to Fetal Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Neoplasm Grading

Share to Prostate

Share to Prostate-Specific Antigen

Share to Prostatectomy

Share to Tissue Array Analysis

Source

Identifiers

PMID: 21683980
DOI: 10.1016/j.humpath.2011.02.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.PMID 21683980Read ↗

Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicatorSemantic proximity Read ↗

Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancerSemantic proximity Read ↗

High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy.Semantic proximity Read ↗

CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion.Semantic proximity Read ↗

Activated leukocyte cell adhesion molecule (CD166/ALCAM): Developmental and mechanistic aspects of cell clustering and cell migrationSemantic proximity Read ↗

Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancerSemantic proximity Read ↗

ALCAM/CD166 Is a TGF-β–Responsive Marker and Functional Regulator of Prostate Cancer Metastasis to BoneSemantic proximity Read ↗

Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites.Semantic proximity Read ↗

CD44 and PTGS2 Methylation are Independent Prognostic Markers for Biochemical Recurrence Among Prostate Cancer Patients with Clinically Localized DiseaseSemantic proximity Read ↗

Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.Semantic proximity Read ↗

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.Semantic proximity Read ↗

An analysis of gene array data related to cell adhesion and prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.